Aurinia Cash Flow - Quarterly (NASDAQ:AUPH)

Add to My Stocks
$5.68 $0.18 (3.27%) AUPH stock closing price Sep 18, 2018 (Closing)

The financial analysis of AUPH requires an investor to check the cash flows for Aurinia. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Aurinia profits and Aurinia debt. Aurinia stock analysis shows negative net income cash flow of $-31.19M till 2018 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. The cash from operating activities for Aurinia is $ 2018 Q2, which saw a decrease from previous quarter.

View and download details of Aurinia cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--1.33M1M--1.31M---
Net Increase (Decrease) in Assets Liabilities-5.09M-3.89M1.69M-0.28M-3.73M-0.24M1.47M-1.56M-1.86M-0.97M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net8.86M4.62M26.58M36.64M35.83M42.14M1.8M1.09M-1.49M-0.31M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.02M-0.02M89.99M-0.01M-0.01M-----
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-10M-20M-97.99M-94.94M-10.05M-3.04M9.99M6.95M6.99M2.95M
Other Cash Inflow (Outflow) from Investment Activities-0.03M------0.01M---
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares3.39M-175.15M166.41M173.85M172.18M9.83M14.92M7.08M-
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---6.53M-2.15M-32.78M-0.84M-0.44M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year165.63M39.64M5.75M22.7M1.82M-----
Cash & Equivalents at Year End132.3M131.22M165.62M87.54M179.71M199.06M39.64M12.33M9.12M3.49M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Aurinia stock price history and Aurinia stock comparison chart inevitably reflect its cash flow situation.

  • Aurinia saw a positive change in Net Change in Cash and Cash Equivalents of $-33.33M till 2018 Q2. Apart from the Aurinia stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Aurinia lost $-26.67M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-10.05M for AUPH till last quarter 2018 Q2 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $3.39M for Aurinia. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Aurinia Cash Flow

Quarterly Cash Flow Statements For Aurinia Pharmaceuticals Inc Peers

Aclaris Therapeutics cash flow, GlobeImmune cash flow, PTC Therapeutics cash flow